Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Choosing the right credit card for international travel can save you money and provide valuable rewards. Explore your best options here.
23,470 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Synopsys stock faces near-term headwinds despite rising revenue, as margins and debt weigh on the long-term outlook. ...
Analogs chip stocks rebound as demand stabilizes and inventories tighten, signaling a cycle turn for the semiconducto...
Stellantis faces a tougher profitability and cash-flow comparison with its peers. But for patient investors, the long...
Tech stocks retreat as geopolitical tensions escalate and oil climbs, sending the live nasdaq composite: tech lower a...
Rivian’s quality metrics, limited service footprint, and steep pricing are prompting investor caution in 2026. This r...
AI advances hinge on memory tech. As the world’s top HBM maker becomes accessible to U.S. investors, learn how this s...
Banks are expanding infrastructure to monetize Bitcoin exposure without holding coins. Strategy's 32% adoption score ...
Pfizer currently draws attention for its high dividend yield, but a big payout can mask risk. This guide explains how...
The FCC is weighing a Know Your Customer style rule that would tie identity to every phone line. Privacy advocates wa...
President Trump signed proclamations shrinking Bears Ears and Grand Staircase-Escalante monuments by roughly 90%, sig...
Coeur Mining is set to release quarterly results as its stock climbs about 203% over the last 12 months. This live co...